How All Sponsors Can Benefit from a Synchronized Outsourcing Strategy

The ebb and flow of a pharmaceutical or biotechnology company’s clinical development portfolio places an emphasis on ensuring that the resources applied can similarly ebb and flow in synchrony with the demand of their portfolio. Historically, in addition to building some capability with internal staff, companies have relied on two possible outsourcing models to provide that synchrony. The first is the classic Clinical Research Organization model (CRO) whose variability is directly related to outsourced projects.

The Evolution of FSP: Not Just for Large Pharma

Explore related content and topics